bioAffinity Technologies (BIAF) shares fell 13% in Wednesday trading after it said it has priced a public offering of 4 million shares of common stock, or pre-funded warrants in lieu thereof, at $0.80 per share for gross proceeds of $3.2 million.
The biotech firm said it expects the offering to close Thursday.
Investors may instead purchase pre-funded warrants at $0.793 each, with each warrant exercisable for one share of common stock.
Price: $0.83, Change: $-0.12, Percent Change: -12.22%